FR 
EN -
Linearis ouvre un nouveau laboratoire afin d’offrir une plateforme analytique d’IA et de biomarqueurs pour l’innovation contre le cancer, le diabète, la résistance aux antimicrobiens et d’autres maladies métaboliques
https://vimeo.com/983745132 Leveraging artificial intelligence (AI), Linearis provides a comprehensive health status based on the analysis of ∼1,300 metabolomic biomarkers through mass spectrometry. The platform will enable its clients to improve prevention, screening, treatment monitoring, and new drug discovery. Québec, Canada, November 28, 2023- Linearis Labs Inc (“Linearis”), an innovative company at the intersection of AI…